Literature DB >> 12961025

[Hyperplasia and tumors of the parathyroid glands].

S-Y Sheu1, F Otterbach, A Frilling, K W Schmid.   

Abstract

Hyperparathyroidism is mainly caused by hyperplasia or adenomas of the parathyroid glands. Formerly, the therapeutic strategy depended on the morphological diagnosis (preferentially already made intraoperatively by examination of frozen sections). Today, however, the extent of parathyroid surgery is in many cases guided both by substantial improvements in the preoperative clinical diagnosis as well as the intraoperatively determined decrease in the serum parathyroid hormone level. Nevertheless, the pathologist should be familiar with the differential diagnostic criteria of parathyroid hyperplasia, adenoma, and carcinoma.

Entities:  

Mesh:

Year:  2003        PMID: 12961025     DOI: 10.1007/s00292-003-0629-6

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  26 in total

1.  Expression of cyclin D1 in parathyroid carcinomas, adenomas, and hyperplasias: a paraffin immunohistochemical study.

Authors:  M A Vasef; R K Brynes; M Sturm; C Bromley; R A Robinson
Journal:  Mod Pathol       Date:  1999-04       Impact factor: 7.842

2.  Positional cloning of the gene for multiple endocrine neoplasia-type 1.

Authors:  S C Chandrasekharappa; S C Guru; P Manickam; S E Olufemi; F S Collins; M R Emmert-Buck; L V Debelenko; Z Zhuang; I A Lubensky; L A Liotta; J S Crabtree; Y Wang; B A Roe; J Weisemann; M S Boguski; S K Agarwal; M B Kester; Y S Kim; C Heppner; Q Dong; A M Spiegel; A L Burns; S J Marx
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

3.  Functioning oxyphil cell adenoma of the parathyroid gland: evidence for parathyroid secretory activity of oxyphil cells.

Authors:  B M Arnold; K Kovacs; E Horvath; T M Murray; H P Higgins
Journal:  J Clin Endocrinol Metab       Date:  1974-03       Impact factor: 5.958

4.  Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.

Authors:  E D Hsi; L R Zukerberg; W I Yang; A Arnold
Journal:  J Clin Endocrinol Metab       Date:  1996-05       Impact factor: 5.958

5.  Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia type 1.

Authors:  A E Bale; J A Norton; E L Wong; J S Fryburg; P N Maton; E H Oldfield; E Streeten; G D Aurbach; M L Brandi; E Friedman
Journal:  Cancer Res       Date:  1991-02-15       Impact factor: 12.701

6.  The intrathyroidal hyperfunctioning parathyroid gland.

Authors:  J Sawady; G Mendelsohn; R L Sirota; J B Taxy
Journal:  Mod Pathol       Date:  1989-11       Impact factor: 7.842

7.  Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1.

Authors:  E Friedman; K Sakaguchi; A E Bale; A Falchetti; E Streeten; M B Zimering; L S Weinstein; W O McBride; Y Nakamura; M L Brandi
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

8.  Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.

Authors:  R V Thakker; P Bouloux; C Wooding; K Chotai; P M Broad; N K Spurr; G M Besser; J L O'Riordan
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

9.  Histopathological variables and DNA cytometry in parathyroid carcinoma.

Authors:  L Bondeson; K Sandelin; L Grimelius
Journal:  Am J Surg Pathol       Date:  1993-08       Impact factor: 6.394

10.  Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.

Authors:  J A Norton; M J Cornelius; J L Doppman; P N Maton; J D Gardner; R T Jensen
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.